Europe business crosses €1 billion as the drugmaker increases focus on regulated markets and biologics.

An FDA inspection of an Aurobindo Pharma manufacturing facility last fall noted more than half a dozen concerns, but at the time the drugmaker indicated they should all be quickly fixable. Now that ...

Track Aurobindo Pharma share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & ...

India-based Aurobindo has been repeatedly knocked by the FDA for its role in global “sartan” recalls for allowing tainted active pharmaceutical ingredients (APIs) into its drugs. Now, a mislabeling ...

Aurobindo has received the Food and Drug Administration’s clearance for three generics. The company received approval for dutasteride & tamsulosin hydrochloride capsules 0.5 mg/0.4 mg, which is the ...

Shares of Aurobindo Pharma declined in Wednesday’s trade, dropping over 4 per cent following reports of lapses observed made by the US drug regulator, the US Food and Drug Administration (US FDA). But ...